Download PDF
Thromb Haemost 1982; 47(02): 096-100
DOI: 10.1055/s-0038-1657137
Original Article
Schattauer GmbH Stuttgart

Activation of Human Coagulation Factor VIII by Activated Factor X, the Common Product of the Intrinsic and the Extrinsic Pathway of Blood Coagulation

K Mertens
The Haemostasis and Thrombosis Research Unit, Leiden University Hospital, Leiden, The Netherlands
,
R M Bertina
The Haemostasis and Thrombosis Research Unit, Leiden University Hospital, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 02 December 1981

Accepted 18 January 1982

Publication Date:
13 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The intrinsic activation of human factor X has been studied in a system consisting of purified factors and in plasma. In both these systems factor Xa stimulated the activation of factor X by factor IXa plus factor VIII This is due to the activation of factor VIII by factor Xa. When this factor Xa is formed via the extrinsic pathway, the extrinsic factor X activator functions as a stimulator of the intrinsic factor X activator.

Key words

Factor VIII - Factor X - Intrinsic pathway - Extrinsic pathway
 

  • References

  • 1 Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-499
    CrossrefPubMedSearch in Google Scholar
  • 2 Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-1312
    CrossrefPubMedSearch in Google Scholar
  • 3 Davie EW, Fujikawa K, Kurachi K, Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzym 1979; 48: 277-318
    PubMedSearch in Google Scholar
  • 4 Jackson CM, Nemerson Y. Blood coagulation. Annu Rev Biochem 1980; 49: 765-811
    CrossrefPubMedSearch in Google Scholar
  • 5 Rapaport SI, Schiffman S, Patch MJ, Ames SB. The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. Blood 1963; 21: 221-236
    PubMedSearch in Google Scholar
  • 6 Macfarlane RG, Biggs R, Ash BJ, Denson KWE. The interaction of factors VIII and IX. Br J Haematol 1964; 10: 530-541
    CrossrefPubMedSearch in Google Scholar
  • 7 Özge-Anwar AH, Connell GE, Mustard JF. The activation of factor VIII by thrombin. Blood 1965; 26: 500-509
    PubMedSearch in Google Scholar
  • 8 Davie EW, Fujikawa K, Legaz ME, Kato H. Role of proteases in blood coagulation. In: Reich E, Rifkin DB, Shaw E. (eds.) Proteases and biological control. Vol. 2 65-77 Cold Spring Harbor Laboratory; Cold Spring Harbor: 1975
    Search in Google Scholar
  • 9 Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980; 19: 401-410
    CrossrefPubMedSearch in Google Scholar
  • 10 Van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3442
    PubMedSearch in Google Scholar
  • 11 Mertens K, Bertina RM. Pathways in the activation of human coagulation factor X. Biochem J 1980; 185: 647-658
    CrossrefPubMedSearch in Google Scholar
  • 12 Kisiel W, Hermodson MA, Davie EW. Factor X activating enzyme from Russell’s viper venom: isolation and characterization. Biochemistry 1976; 15: 4901-4906
    CrossrefPubMedSearch in Google Scholar
  • 13 Bertina RM, Veltkamp JJ. The abnormal factor DC of hemophilia B+ variants. Thromb Haemostas 1978; 40: 335-349
    PubMedSearch in Google Scholar
  • 14 Lindquist PA, Fujikawa K, Davie EW. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell’s viper venom. J Biol Chem 1978; 253: 1902-1907
    PubMedSearch in Google Scholar
  • 15 Van den Besselaar AMHP, Ram IE, Bertina RM. Involvement of human factor IX in tissue thromboplastin induced coagulation. Thromb Haemostas 1981; 46: 34 (Abstr)
    PubMedSearch in Google Scholar
  • 16 Bertina RM, Veltkamp JJ. A genetic variant of factor IX with decreased capacity for Ca2+ binding. Br J Haematol 1979; 42: 623-635
    CrossrefPubMedSearch in Google Scholar
  • 17 Bertina RM, Van der Linden IK, Muller HP, Derks J, Klein-Breteler E. A monoclonal anti human factor IX produced by a mouse hybridoma. Thromb Haemostas 1981; 46: 165 (Abstr)
    PubMedSearch in Google Scholar
  • 18 Bertina RM, Westhoek-Kuipers MEJ, Alderkamp GHJ. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment. Thromb Haemostas 1981; 45: 237-241
    PubMedSearch in Google Scholar
  • 19 Bertina RM, Orlando M, Tiedemann-Alderkamp GHJ. Preparation of a human factor VII deficient plasma. Thromb Res 1978; 13: 537-541
    CrossrefPubMedSearch in Google Scholar
  • 20 Veltkamp JJ, Drion EF, Loeliger EA. Detection of the carrier state in hereditary coagulation disorders. I. Thrombos Diathes Haemorrh 1968; 19: 279-303
    PubMedSearch in Google Scholar
  • 21 Bertina RM, Van der Marel-van Nieuwkoop W, Loeliger EA. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants. Thromb Haemostas 1979; 42: 1296-1305
    PubMedSearch in Google Scholar
  • 22 Ødegård OR, Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 1975; 6: 287-294
    CrossrefPubMedSearch in Google Scholar
  • 23 Muller HP, Van Tilburg NH, Bertina RM, Terwiel JP, Veltkamp JJ. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG). Clin Chim Acta 1980; 107: 11-19
    CrossrefPubMedSearch in Google Scholar
  • 24 Neal GG, Chavin SI. The role of factors VIII and IX in the activation of bovine blood coagulation factor X. Thromb Res 1979; 16: 473-484
    CrossrefPubMedSearch in Google Scholar
  • 25 Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-5264
    CrossrefPubMedSearch in Google Scholar
  • 26 Zur M, Nemerson Y. Kinetics of factor IX activation via the extrinsic pathway. J Biol Chem 1980; 255: 5703-5707
    PubMedSearch in Google Scholar
  • 27 Bertina RM, Van der Linden IK. Activation of normal and abnormal (genetic variant) human factor IX. Thromb Haemostas 1979; 42: 364 (Abstr)
    PubMedSearch in Google Scholar
  • 28 Jesty J, Silverberg SA. Kinetics of the tissue factor-dependent activation of coagulation factors IX and X in a bovine plasma system. J Biol Chem 1979; 254: 12337-12345
    PubMedSearch in Google Scholar
  • 29 Østerud B, Rapaport SI. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Scand J Haematol 1980; 24: 213-226
    PubMedSearch in Google Scholar
  • 30 Østerud B. The intrinsic and extrinsic activation of factor IX. In: Peeters H. Protides of the biological fluids. Vol. 28 233-236 Pergamon Press; Oxford: 1980
    Search in Google Scholar
  • 31 Marlar RA, Griffin JH. Alternative pathways of thromboplastin-dependent activation of human factor X in plasma. Ann NY Acad Sci 1981; 370: 325-335
    CrossrefPubMedSearch in Google Scholar
  • 32 Biggs R, Nossel HL. Tissue extract and the contact reaction in blood coagulation. Thrombos Diathes Haemorrh 1961; 6: 1-14
    PubMedSearch in Google Scholar
  • 33 Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thrombos Diathes Haemorrh 1965; S17: 35-44
    PubMedSearch in Google Scholar